SPRO - Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M
2024-01-05 08:19:04 ET
More on Spero Therapeutics
- Spero Therapeutics Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Spero Therapeutics
- Historical earnings data for Spero Therapeutics
- Financial information for Spero Therapeutics
For further details see:
Spero Therapeutics says cash and cash equivalents as of December 31 were about $76.3M